In an industry with financial margins so high they induce nosebleeds in consumers and policy-makers alike, it’s surprising how little attention is paid to biopharma’s equally vast reserves of human capital. By nearly every indication, the industry and its fellow travelers in the life sciences possess the most productive, knowledge-intensive, highly educated and well-compensated workforce in the world. Nevertheless, this disconnect deserves its own question: can we affirm that all is well in this most comfortable of career destinations?
To find out, In Vivo, together with Informa’s newly launched life sciences learning business, EBD Academy, conducted a comprehensive survey...
